Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bristol’s Nutritionals Business Spins Out; IPO Well-Received By Investors

This article was originally published in The Pink Sheet Daily

Executive Summary

Mead Johnson Nutrition offering breaks health care IPO drought.

You may also be interested in...

RB Eyes MJN, Spiked Supplements, GMP Warning: Health & Wellness Industry News Roundup

RB eyes acquiring MJN; weight loss, ED drugs found in supplements; Unique EnCapsulation has GMP, water, expiration date problems; and SSCI Benchmark panel nominees sought.

Are Emerging Markets Part Of Big Pharma's Core Business?

As Big Pharma companies increasingly look to emerging markets to capture some of the growth lost from the patent cliff in the U.S. and Europe, they are also shifting focus more to branded generics, leaving some investors to question whether companies would be better off spinning out their emerging market units, which would leave behind smaller companies focused on the core business of developing and marketing innovative therapies

Cumberland Pharmaceuticals Raises $85 Million In IPO

First public offering for the pharmaceutical sector in 21 months suggests a financial thaw, but unlikely to spark an additional flood of deals.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts